Related Experiment Video
Updated: Apr 30, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Wirsching Psychosocial Risk Scale (WPRS) Versus Outcome in Patients With Breast Disease and Breast Cancer: A
Matti Eskelinen1, Riika Koskela2, Tuomas Selander3
1Department of Surgery, Kuopio University Hospital (KUH) and School of Medicine, University of Eastern Finland (UEF), Kuopio, Finland.
Background/Aim:
This study evaluated whether Wirsching Psychosocial Risk (WPR) scale for measuring the severity of psychosocial risk (PR) factors can predict the long-term outcomes in patients having breast carcinoma (BC) symptoms.
Patients And Methods:
A totalof 115 patients with BC symptoms completed the WPR scale and associations between WPR scale and long-term outcome were analyzed using survival models.
Results:
The WPRS scores correlated to Beck Depression Inventory (BDI) (r=0.382, p<0.001), to Montgomery-Asberg Depression Rating Scale(MADRS) (r=0.517, p<0.001), to Forsen inventory (FI) during 0-2 years (r=0.392, p<0.001) and FI 2-6 years (r=0.397, p<0.001) prodromal periods and to State-Trait Anxiety inventory (STAI) (r=0.131, p=0.164) levels.In the Cox model, the WPR scale predicted the 25-year relapse-free survival (RFS) in patients with BC [hazard ratio (HR)=1.76, p=0.197] and the WPR scale predicted 25-year overall survival (OS) in women with BC symptoms (HR=2.31, p=0.019) and women with BC (HR=2.12, p=0.09). In the Kaplan-Meier survival analysis by the log-rank test, the 25-year relapse rate differed between low WPRS score (<21) versus the high WPRS score (≥21) in patients with BC (37.5% versus 20%, log-rank p-value=0.195). Also, the low WPRS score (<21) was a favorable predictor of RFS [HR=1.50, 95% confidence interval (CI)=0.80-2.99, p=0.199] in the patients with BC symptoms. The 25-year OS rate differed significantly between low WPRS score (<21) versus high WPRS score (≥21) patients with BC symptoms (74.4% versus 53.0%, log-rank p-value=0.016). A similar pattern was seen in patients with BC as the WPRS score predicted 25-year OS in women with BC (45.8% versus 20.0%, log-rank p-value=0.088).
Conclusion:
The studies assessing the impact of PR factors on outcome of patients with BC symptoms have not reported WPRS levels. In the present study, a 25-year follow-up of patients with BC symptoms enables us to detect the 25-year outcome and to assess the RFS and OS versus WPRS approach using Kaplan-Meier and Cox proportional hazard models. The study showed that the PR variables detected with the WPR scale significantly correlate to the 25-year OS in patients with BC and 25-year OS in patients with BC symptoms. Therefore, the use of WPRS inventory detecting PR factors should be considered as a useful part of the diagnostic protocol of patients with BC symptoms.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
